The OpenAI chatbot ChatGPT is an artificial intelligence (AI) application that uses state-of-the-art language processing AI. It can perform a vast number of tasks, from writing poetry and explaining complex quantum mechanics, to translating language and writing research articles with a human-like understanding and legitimacy. Since its initial release to the public in November 2022, ChatGPT has garnered considerable attention due to its ability to mimic the patterns of human language, and it has attracted billion-dollar investments from Microsoft and PricewaterhouseCoopers. The scope of ChatGPT and other large language models appears infinite, but there are several important limitations. This editorial provides an introduction to the basic functionality of ChatGPT and other large language models, their current applications and limitations, and the associated implications for clinical practice and research. Cite this article:
Cite this article:
Cite this article:
Cite this article:
Cite this article:
Cite this article:
Cite this article:
The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells, exosomes, and genes is summarized along with the author’s perspectives. Despite a tremendous interest, so far there is very little evidence proving the efficacy of this modality for clinical application. As symptomatic relief is not sufficient to justify the high cost associated with regenerative medicine, definitive structural improvement that would last for years or decades and obviate or delay the need for joint arthroplasty is essential for regenerative medicine to retain a place among OA treatment methods. Cite this article:
In cerebral palsy, the site and severity of the brain lesion are directly linked to gross motor
Traditionally, informed consent for clinical
research involves the patient reading an approved Participant Information
Sheet, considering the information presented and having as much time
as they need to discuss the study information with their friends
and relatives, their clinical care and the research teams. This
system works well in the ‘planned’ or ‘elective’ setting. But what
happens if the patient requires urgent treatment for an injury or emergency? This article reviews the legal framework which governs informed
consent in the emergency setting, discusses how the approach taken
may vary according to the details of the emergency and the treatment
required, and reports on the patients’ view of providing consent
following a serious injury. We then provide some practical tips
for managing the process of informed consent in the context of injuries
and emergencies. Cite this article:
The limitations and benefits of patient-reported
outcome measures, in defining the merits of arthroplasty surgery,
are discussed. Cite this article:
The effective capture of outcome measures in
the healthcare setting can be traced back to Florence Nightingale’s
investigation of the in-patient mortality of soldiers wounded in
the Crimean war in the 1850s. Only relatively recently has the formalised collection of outcomes
data into Registries been recognised as valuable in itself. With the advent of surgeon league tables and a move towards value
based health care, individuals are being driven to collect, store
and interpret data. Following the success of the National Joint Registry, the British
Association of Spine Surgeons instituted the British Spine Registry.
Since its launch in 2012, over 650 users representing the whole
surgical team have registered and during this time, more than 27 000
patients have been entered onto the database. There has been significant publicity regarding the collection
of outcome measures after surgery, including patient-reported scores.
Over 12 000 forms have been directly entered by patients themselves,
with many more entered by the surgical teams. Questions abound: who should have access to the data produced
by the Registry and how should they use it? How should the results
be reported and in what forum? Cite this article:
